Opiant Pharmaceuticals Inc. | Ownership
Companies that own Opiant Pharmaceuticals Inc.
The Vanguard Group, Inc.
84,281
3.13%
3,550
0%
06/30/2018
Northern Trust Investments, Inc.
24,372
0.9%
24,372
0%
06/30/2018
Acadian Asset Management LLC
6,418
0.24%
-3,699
0%
06/30/2018
BlackRock Fund Advisors
6,280
0.23%
6,280
0%
06/30/2018
O'Shaughnessy Asset Management LLC
4,429
0.16%
-983
0%
06/30/2018
RBC Capital Markets LLC (Investment Management)
3,788
0.14%
3,788
0%
06/30/2018
UBS Financial Services, Inc.
1,550
0.06%
-2,350
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
490
0.02%
130
0%
06/30/2018
Arbor Point Advisors LLC
455
0.02%
0
0%
06/30/2018
BlackRock Investment Management LLC
454
0.02%
454
0%
06/30/2018
| Address |
201 Santa Monica Boulevard
Santa Monica California 90401
United States
|
|
Employees
|
- |
| Website |
http://www.opiant.com |
| Updated |
07/08/2019 |
| Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. |
